about
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonistViral Evasion of Natural Killer Cell ActivationUnderground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsNatural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer ImmunotherapyHTLV-1 ORF-I Encoded Proteins and the Regulation of Host Immune Response: Viral Induced Dysregulation of Intracellular SignalingMechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of GlutathioneNK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer ImmunotherapyA Novel Method for Assessment of Natural Killer Cell Cytotoxicity Using Image CytometryAn NK Cell Perforin Response Elicited via IL-18 Controls Mucosal Inflammation Kinetics during Salmonella Gut InfectionImmunological and Translational Aspects of NK Cell-Based Antitumor ImmunotherapiesDendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer functionFc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.Long-term effect on natural killer cells by interferon-α therapy on the outcomes of HCV infection.Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).Immunobiology of the TAM receptors.Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansionAutophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.Exploiting the critical perioperative period to improve long-term cancer outcomesImmunological mechanism of the low-dose radiation-induced suppression of cancer metastases in a mouse modelNatural killer cells control a T-helper 1 response in patients with Behçet's disease.Fasting enhances TRAIL-mediated liver natural killer cell activity via HSP70 upregulationPreservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach.Using an agent-based model to analyze the dynamic communication network of the immune response.DAP12: an adapter protein with dual functionality.Intra-abdominal fat depots represent distinct immunomodulatory microenvironments: a murine model.Comparative efficiency of HIV-1-infected T cell killing by NK cells, monocytes and neutrophils.Potential role of NK cells in the pathogenesis of inflammatory bowel disease.NK cell immunesenescence is increased by psychological but not physical stress in older adults associated with raised cortisol and reduced perforin expression.Metastatic colon cancer cell populations contain more cancer stem-like cells with a higher susceptibility to natural killer cell-mediated lysis compared with primary colon cancer cells.Secreted β3-integrin enhances natural killer cell activity against acute myeloid leukemia cells.Reduced degranulation of NK cells in patients with frequently recurring herpes.Cell docking, movement and cell-cell interactions of heterogeneous cell suspensions in a cell manipulation microdevice.Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma.Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.Immunohistochemical analysis of the natural killer cell cytotoxicity pathway in human abdominal aortic aneurysms.Killer-cell immunoglobulin-like receptors and malaria caused by Plasmodium falciparum in The Gambia.Killer cell immunoglobulin-like receptor (KIR) gene content variation in the HGDP-CEPH populations.The Basic Immune Simulator: an agent-based model to study the interactions between innate and adaptive immunityMaintenance biotherapy with interleukin-2 and interferon for metastatic renal cell cancer.
P2860
Q24623979-BD0D586B-6DEF-48E2-AD23-7FE0F58EFA44Q26748421-B8D63C8D-3A17-436C-9F6A-5BB4B7ECE2CDQ26751011-F4F3153B-44AE-43EC-B8ED-E68BB9423FC1Q26772347-B9E12CD6-F5B2-410C-AA4F-85BBF7BABA50Q26777804-24D39C47-13F0-487C-BE68-B18225A419BBQ26779214-D18BC21E-D71E-41A5-97C2-E2C06F4EFCC6Q26797345-66286FAC-5E83-4A36-B82C-3EC9DE27C680Q27312227-6D29FF61-FA2A-4561-9C19-7EEC2FF8D688Q27313075-5D1B52E7-1A47-42CB-A13C-460E496773DCQ28079180-B3195E92-3DDA-4430-8C8B-FC8E8FBCD1E8Q28854563-92E34367-5B8C-4DB8-86A0-D4AF7C4E9018Q30400230-7ED5044E-758C-4938-A109-95BC4595E993Q33315601-1244C103-2A1E-4CED-AC08-6437CE749B6DQ33588171-A0896763-634E-4E2B-A6A5-B29A560426B0Q33672480-BB57167C-F051-4DA9-A9CC-5B4D7D901952Q33796991-8301590A-A6C7-4D15-B972-0A9FC943365BQ33816097-75FD07B1-C941-466F-8B19-E47FF685673EQ33839054-9E199F6D-1B9C-4A96-83F6-AE97B0036E8DQ33871661-3634DFB4-2E9A-4A5F-8C48-2CDDF243C888Q33929137-C11F7374-28C8-434E-B8CC-5B0EDC3A2CA6Q34027448-0CDDFF32-4CE7-4A23-9D40-828124C2F014Q34428370-334401B0-6A73-41AB-9E4E-84C61B246C67Q34441128-8F4DCC51-2984-4E43-BB70-E4A3EC41AE4BQ34547306-FB9FB01B-45E4-40FC-A8E0-F31B1874A804Q34581211-F584992B-EE6D-4C38-B71A-324E5898DB64Q34776726-27CDA6B2-8CC9-4C95-809B-0F7FA86EEFD3Q34990389-851AFB17-0E40-4A53-8C4B-C68B38A23019Q35043975-FEC43EED-F5A6-4351-AF88-F666B281116FQ35058981-08E49ED4-7534-4E6C-9FB2-F7B144872E2FQ35167855-63F87D04-7249-4A55-AC8C-5CACC8470642Q35185573-66F1F637-E6B7-4C35-A62A-4F0196522EA8Q35191244-BBDD436B-F9CC-4265-B574-D2857D0D4CD7Q35594202-388646C4-78E9-4FD8-8172-859241FFA12FQ35597405-371D67BB-F96B-45CB-907C-548F7955D585Q35632513-5FFC13B3-DF8C-4CB3-92F2-A4A9E6E8BCD3Q35723676-3EB3D837-8FB1-4812-9A2E-1D2A5FE9889EQ35873703-C9B02B80-AE43-494F-B80B-FF502DA4412BQ36223646-21ED39C4-0ECF-4CB9-8150-49DBC390F3E9Q36345148-B3368E38-B059-4FC5-98B5-3F6D97AB7012Q36352105-B0F23E55-F5EA-44A2-A52A-8D0A6017FB1D
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Activation of NK cell cytotoxicity.
@ast
Activation of NK cell cytotoxicity.
@en
type
label
Activation of NK cell cytotoxicity.
@ast
Activation of NK cell cytotoxicity.
@en
prefLabel
Activation of NK cell cytotoxicity.
@ast
Activation of NK cell cytotoxicity.
@en
P2093
P1433
P1476
Activation of NK cell cytotoxicity.
@en
P2093
Erika Cretney
Janice M Kelly
Jennifer A Westwood
Kazuyoshi Takeda
Mariapia A Degli-Esposti
Serani L H van Dommelen
Shayna E A Street
Yoshihiro Hayakawa
P304
P356
10.1016/J.MOLIMM.2004.07.034
P577
2005-02-01T00:00:00Z